COVID-19 Information and Resources

We’re taking steps to ensure the health and well-being of our employees and their families, the patients and families we serve, and the communities in which we live and work. Our actions have been, and will continue to be, driven by science, data and thoughtful policy approaches, as well as by empathy and compassion for those who are at particular risk from this virus. 

Patients are the center of everything we do at Vertex. We know you’re counting on us and we’ve taken steps to ensure a continuous supply of our medicines during the COVID-19 pandemic. We have constructed our supply chains to ensure readiness for a wide variety of contingencies, and we have ample supply to meet our commercial needs now and into the future. We are highly confident in our ability to continue to supply all of our medicines to patients around the world who rely on them. Additionally, the company's manufacturing facilities are operational and continue to produce our medicines. 

For patients enrolled in our clinical trials, your health and safety is always our top priority, followed by our commitment to bring these medicines to people who need them as quickly as possible. We’re working closely with clinical trial sites and investigators across all of our programs to provide additional support or guidance they need related to COVID-19. For ongoing studies, we’re working with sites to enable virtual clinic visits and home delivery of study medicines to ensure study continuity and medical monitoring, and to facilitate study procedures. 

Contact Information 

As the pandemic continues to evolve, we’d like to help guide you to where you can reach out with questions you may have. 

  • If you’re a patient or a caregiver of a patient in the U.S. who is enrolled in Vertex GPS™: Guidance & Patient Support, please reach out to us at +1 877-752-5933 (press 2 to speak to a Patient Support Specialist). Our program is open, fully operational and ready to support enrolled patients. 

  • Please contact your health care provider if: 

    • You’re a patient or a caregiver of a patient in the U.S. who is not currently enrolled in Vertex GPS™: Guidance & Patient Support 

    • You’re a patient or a caregiver of a patient outside the U.S. 

  • If you’re a health care provider, please reach out to Vertex Global Medical Information. Visit to find contact information for your region. 

  • If you’re a clinical trial site, please reach out to your Vertex point of contact or reach out to Vertex Global Medical Information. Visit to find contact information for your region. 


Resources for Patients and Health Care Providers

Below are a few resources that have information related to COVID-19 that you may find helpful. You may also want to check out local organizations in your area as they may provide more specific information about your condition and/or region. 

COVID-19 Resources 

Alpha-1 Antitrypsin Deficiency Resources 

APOL1-Mediated Focal Segmental Glomerulosclerosis Resources 

Cystic Fibrosis Resources 

Duchenne Muscular Dystrophy Resources 

Hemoglobinopathies Resources 

Type 1 Diabetes Resources 

The health and safety of our employees and their families, and the patients we serve, remain our top priorities. All of our employees are essential, and together we have important work to do. Throughout the pandemic, we’ve taken proactive steps to adapt, including shifting a significant proportion of our employees to full-time remote work and adapting our benefits and programs. 

While some of our employees continue to work remotely, some employees who need the building for their work continue to work on-site. For example, our colleagues at the Vertex Manufacturing Center (VMC) continue their outstanding work to ensure our facilities remain safe and operational and continue to produce new supplies of our medicines. As we start to safely increase capacity at our sites, we’re taking a phased and site-specific approach that is determined by closely monitoring local case trends and government guidance for each location. In addition to limiting population density at our sites, here’s what we’re doing to keep our on-site employees safe: 

  • We’ve increased our safety measures, which are informed by best practices prescribed by both the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO).  

  • We hosted an on-site COVID-19 vaccine clinic in Boston in May and June for employees and contractors in Mass. and R.I. who had not yet received any COVID-19 vaccine. 

  • We’re committed to flexibility and are working with on-site employees to find remote solutions for anyone who does not feel comfortable working on-site. 

Here are just a few of the ways we’ve adapted our benefits and programs to support all of our employees: 

  • If employees are unable to work due to potential or actual exposure to COVID-19, or if they need to adjust their schedule to get the COVID-19 vaccine or respond to responsibilities at home, their time away from work will be paid and will not impact benefits, job status or paid time off (vacation or sick leave). 

  • We’ve launched several mental health and wellness initiatives, including a free subscription to the Headspace meditation app for all employees globally and a dedicated “Healthy Mind” intranet site. The intranet site provides tools and resources for managing grief and dealing with stress and anxiety, including information about employee assistance programs and virtual consultations with medical professionals. It’s also a space for employees to connect with each other around their shared experiences. 

  • We’ve added additional company-wide time off, because we recognize these unprecedented times and the challenges of balancing work, family and home responsibilities. We are also encouraging everyone to take paid time off as they typically would. 

  • For employees who are working remotely, we’ve provided resources to set up work-from-home capabilities.  

We’re proud of the strong culture of innovation and inclusion we’ve built at Vertex, and this has been evident in how our teams have responded to these unforeseen circumstances. We’re continuing to monitor the ever-changing situation and are regularly assessing whether our approach needs to evolve. 


In addition to doing what we can for our Vertex employees, we’re taking action to support the broader communities in which we operate globally in relation to this outbreak. The Vertex Foundation committed $5 million to support on-the-ground COVID-19 pandemic response efforts in our local communities, focused on essential health care and health supplies and providing support for vulnerable populations. This includes a $1 million donation to Direct Relief and a $1 million donation to help establish the Boston Resiliency Fund, as well as donations to several other relief organizations in the U.K., Italy, France, Spain, Germany, Canada, Brazil and the U.S. (including Vertex communities of Massachusetts and San Diego). To extend Vertex’s impact even further, the Foundation offered special 2:1 match opportunities for employees to donate to more than 120 organizations, including many that are focused on global COVID-19 relief efforts.

Vertex is also committed to supporting the cystic fibrosis community and other patient communities in areas where we focus our research where possible during this pandemic. Requests for support should be directed through the Vertex Grants portal.  


Related Information for the Community
  • June 15, 2020 Vertex news release: The Vertex Foundation Announces Donation to ARCAH to Help With COVID-19 Response 

  • June 15, 2020 Vertex news release: The Vertex Foundation Announces Donation to Tafel Deutschland to Help With COVID-19 Response 

  • April 24, 2020 Vertex news release: The Vertex Foundation Announces Donation to Food Banks Canada to Help With COVID-19 Response 

  • April 7, 2020 Vertex news release: The Vertex Foundation Commits $5 Million to Support Global COVID-19 Pandemic Response 

  • March 16, 2020 City of Boston news release: Boston Resiliency Fund to Support Residents Most Impacted by Coronavirus Pandemic 

  • March 13, 2020 Vertex news release: The Vertex Foundation Donates $500,000 to Partners HealthCare to Support COVID-19 Outbreak Response 


Despite the widespread impact of the COVID-19 pandemic, we continue to be highly confident in our supply chain and our ability to supply all of our approved medicines to patients who need them. The COVID-19 pandemic is a rapidly evolving global health crisis that will require unprecedented utilization of health care resources that we expect will have an impact on our clinical trials. In order to ensure patient safety and the appropriate use of health care resources and to maintain study integrity, we have made proactive changes to some of our ongoing and planned clinical trials. For more information, visit


Vertex is a registered trademark of Vertex Pharmaceuticals Incorporated. 
Vertex GPS is a trademark of Vertex Pharmaceuticals Incorporated.
All other trademarks are the property of their respective owners.